(Q78592533)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12458683%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

title

Complexation of VEGF with bevacizumab decreases VEGF clearance in rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12458683%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1 reference

Vanessa Hsei

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12458683%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Geralyn G Deguzman

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12458683%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Alison Nixon

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12458683%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Jacques Gaudreault

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12458683%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

publication date

1 November 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12458683%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

published in

Pharmaceutical Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12458683%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12458683%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12458683%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

page(s)

1753-1756

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12458683%20AND%20SRC:MED&resulttype=core&format=json

Characterization of complex formation by humanized anti-IgE monoclonal antibody and monoclonal human IgE.

15 December 2019

cites work

1 reference

12 December 2020

Preclinical pharmacokinetics, interspecies scaling, and tissue distribution of a humanized monoclonal antibody against vascular endothelial growth factor.

1 reference

12 December 2020

Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group.

1 reference

12 December 2020

Complete inhibition of rhabdomyosarcoma xenograft growth and neovascularization requires blockade of both tumor and host vascular endothelial growth factor.

1 reference

12 December 2020

Tissue distribution and complex formation with IgE of an anti-IgE antibody after intravenous administration in cynomolgus monkeys

1 reference

12 December 2020

The biology of vascular endothelial growth factor

1 reference

12 December 2020

Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders

1 reference

12 December 2020

What Is the Evidence That Tumors Are Angiogenesis Dependent?

1 reference

12 December 2020

Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer

1 reference

12 December 2020

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

1 reference

12 December 2020

New functions of the MHC class I-related Fc receptor, FcRn

1 reference

12 December 2020

Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro.

1 reference

12 December 2020

Consequences of angiogenesis for tumor progression, metastasis and cancer therapy.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1020778001267

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12458683%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1 reference